Third FDA panel member quits over controversial Alzheimer’s drug approval
June 11, 2021Medical Communications
The third FDA advisory panel member has quit over the approval of a controversial new Alzheimer’s drug. Biogen’s drug, aducanumab, …
“The future of pain care”: Virtual reality therapy proven to aid chronic pain
June 11, 2021Medical Communications CBT, Virtual reality, chronic pain management, technology
A novel digital therapeutics software, DTxP, has shown statistically significant benefits for patients with chronic low back pain (CLBP) in …
G7: UK to donate 100 million surplus vaccine doses
June 11, 2021Medical Communications Boris Johnson, COVID-19, G7, Joe Biden, UK, US, Vaccine
Boris Johnson has announced at the G7 meeting in Cornwall that the UK will donate over 100 million surplus doses …
Sutimlimab meets primary endpoint in treating cold agglutinin disease
June 11, 2021Medical Communications
A Phase III study evaluating the safety and efficacy of sutimlimab in people with cold agglutinin disease (CAD) met its …
Pharmafile.com’s top 10 news stories of the week
June 11, 2021Medical Communications
Among our ten most-read stories this week: AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions; New …
Phase III breast cancer trial meets primary endpoint
June 10, 2021Byondis has revealed positive Phase III results for (ADC) [vic-]trastuzumab duocarmazine (SYD985) in patients with HER2-positive unresectable locally advanced or …
Pharmafile.com’s weekly COVID-19 news round-up
June 10, 2021The past week has seen lots of vaccine-related news, Pfizer-BioNTech has expanded its COVID-19 vaccine study in children under 12, …
NICE release new guidance on rheumatoid arthritis treatment
June 10, 2021NICE, biosimilar, rheumatoid arthritis
NICE has today published final draft guidance for the treatment of moderate rheumatoid arthritis in patients who have not responded …
SMC approves nintedanib for patients with chronic lung disease
June 10, 2021The Scottish Medicines Consortium (SMC) has approved nintedanib for NHSScotland for the treatment of adult patients with chronic fibrosing interstitial …
COVID chaos: Survey reveals global oncology trial disruptions
June 10, 2021data, oncology
The pandemic has had a widespread impact across the healthcare industry and the world, however, a recent global survey from …
Pfizer to expand COVID vaccine study in children under 12
June 10, 2021COVID-19, Pfizer, Vaccine
Pfizer has announced that it will begin large-scale testing of its COVID-19 vaccine after selecting a lower dose of the …
Phase III trial supports the potential use of Cabometyx for thyroid cancer
June 8, 2021Manufacturing and Production
Ipsen and Exelixis have announced detailed results from the Phase III COSMIC-311 pivotal trial of Cabozantinib in patients with previously …
FDA approves first new Alzheimer’s drug in two decades
June 8, 2021Manufacturing and Production
Biogen’s controversial new drug, aducanumab, has been accepted by the FDA, making it the first Alzheimer’s drug to be approved …
MHRA approves venetoclax as acute myeloid leukemia treatment
June 8, 2021Manufacturing and Production EC, EU, MHRA, leukemia
The MHRA has announced its approval for AbbVie’s venetoclax, in combination with a hypomethylating agent, for the treatment of newly …
MSD announce new data from advanced renal cell carcinoma trial
June 8, 2021Manufacturing and Production MSD, rcc
Merk (MSD) has announced positive data from its Phase III Clear/Keynote-581 trial on Keytruda (pembrolizumab) plus Lenvima (lenvatinib), and Lenvima …
New NICE recommendation for Astellas prostate cancer drug
June 8, 2021Manufacturing and Production Astellas, NICE, prostate cancer
A newly published Final Appraisal Determination by NICE has recommended Astellas’ Xtandi (enzalutamide) plus androgen deprivation therapy (ADT), as an …
Astronomy & cancer: Researchers join forces to study CUP
June 7, 2021Sales and Marketing oncology
Astronomers from Durham University have joined forces with cancer researchers to advance the diagnosis and treatment of cancer of unknown …
UK vaccination update
June 7, 2021Sales and Marketing
With 21 June fast approaching, and the Delta variant rising in the UK, here’s the latest vaccine update. Firstly, the …
AstraZeneca vs GSK: Cancer drug court battle could cost hundreds of millions
June 7, 2021Sales and Marketing AstraZeneca, GSK, court
AstraZeneca has launched a court case against Glaxo Smith Kline (GSK), in a claim that could reach hundreds of millions …
MHRA confirms registration of Avacta’s lateral flow test
June 7, 2021Sales and Marketing COVID-19, EU, MHRA, lateral flow test
Avacta has announced that the MHRA has confirmed registration of the AffiDX SARS-CoV-2 antigen lateral flow test, which allows the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
